Nalaganje...

Minimal Residual Disease in Multiple Myeloma: Current Landscape and Future Applications With Immunotherapeutic Approaches

The basic principle that deeper therapeutic responses lead to better clinical outcomes in cancer has emerged technologies capable of detecting rare residual tumor cells. The need for ultra-sensitive approaches for minimal residual disease (MRD) detection is particularly evident in Multiple Myeloma (...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Oncol
Main Authors: Kostopoulos, Ioannis V., Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Tsitsilonis, Ourania E., Terpos, Evangelos
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7267070/
https://ncbi.nlm.nih.gov/pubmed/32537439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00860
Oznake: Označite
Brez oznak, prvi označite!